Mos Health Raises €920K for AI Health Partner

Mos Health raises nearly €920k to build AI Health Partner MVP and begin U.S. deployments

Polish-American startup Mos Health has raised nearly €920k ($1.1 million) in a pre-seed round to build its MVP, develop its core technology, and start its first deployments in the United States. The round was co-led by SMOK Ventures and Movens Capital, with participation from Tomasz Karwatka, Piotr Karwatka, and Anna Lankauf, among others.

From the lens of the ai world organisation, this is another clear signal that preventive health is moving from “information and motivation” toward “systems and execution,” especially when AI is paired with tangible product layers that help users follow through. As we track what’s shaping the next wave of applied AI, stories like this are exactly what we highlight across the ai world summit ecosystem and wider ai world organisation events, where founders and operators compare what actually drives adoption in real life rather than what only looks good in demos. In that spirit, this coverage connects the dots for readers following ai world summit 2025 / 2026 conversations and the broader shift we’re seeing at ai conferences by ai world.

A pre-seed round focused on product, not hype

Mos Health positions itself as an “AI Health Partner” that blends personalised health protocols with matched supplementation. The company says the new funding will be used to build its MVP, strengthen the underlying technology, and initiate early U.S. deployments.

The investor line-up reflects a familiar early-stage pattern: backing repeat operators with a clear wedge into a large market, then financing speed-to-MVP and speed-to-distribution at the same time. Mos Health’s round was co-led by SMOK Ventures and Movens Capital, with additional participation from individual backers including Tomasz Karwatka, Piotr Karwatka, and Anna Lankauf.

Founder Patrycja Brzozowska frames the company’s origin as a personal consistency problem, arguing that generic advice fails because it doesn’t use individual data or reduce the friction of execution. She describes Mos Health as the “partner” she wished existed, designed to guide users step-by-step rather than leaving them to translate recommendations into daily action on their own.

The team: operators with prior wellness experience

Mos Health was founded by Patrycja Brzozowska and is described as a preventive health and lifestyle wellness company. Before Mos Health, Brzozowska was the COO and a founding team member at Wellbee, a Polish mental health platform for employees that was acquired in 2024 by Benefit Systems.

The founding team also includes Paweł Chrzan, identified as a co-founder of Wellbee, and Paweł Sobkowiak, described as a former CTO at Booksy. On the investor side, SMOK Ventures Partner Borys Musielak emphasised the founders’ “successful exit in Poland” and their ambition to win bigger globally, adding that SMOK decided to back Mos Health within days of meeting the team and is rooting for its U.S. expansion.

From an ecosystem standpoint, this is the kind of founder profile we often see resonate in discussions at the ai world summit: people who have already built in adjacent categories, learned where engagement breaks, and now rebuild the product around the behaviour gap instead of around content alone. For the ai world organisation, this “second-time founder + focused distribution channel” setup is frequently where early traction becomes repeatable rather than accidental, which is why it’s a recurring theme across ai world organisation events.

Two pillars: an AI dashboard plus a supplement “execution layer”

Mos Health’s core claim is that the biggest issue in wellness is not knowledge—it’s follow-through, which it calls an “execution gap.” The company says that only 25% of U.S. adults are sufficiently active and that most diets fail because people struggle to maintain sustainable routines over time.

To address that, Mos Health describes a two-part system. The first pillar is the AI Health Partner app, presented as a dashboard that analyses inputs such as sleep, diet, lab results, and wearable data—including devices like Apple Watch and Oura—to generate personalised health protocols.

The second pillar is proprietary supplementation: a supplement line manufactured with a partner in the United States and intended to act as a physical “execution layer” for what the app recommends. This pairing is strategically interesting because it tries to close the loop between “insight” and “action,” making the protocol easier to implement without requiring users to shop, compare, and decide on supplements separately.

From our perspective at the ai world organisation, this product architecture also fits a broader AI adoption lesson we see across multiple sectors: AI often “sticks” when it’s embedded into a workflow and backed by real-world scaffolding, not when it stops at personalised advice. It’s a useful case study for founders and operators who attend the ai world summit to learn how AI product strategy changes when success is measured in adherence and long-term outcomes instead of clicks.

Why the U.S. launch is employer-led (B2B2C)

Mos Health says it is launching in the U.S. through a B2B2C model, enabling employers to offer “health-as-a-service” to their teams. The company’s pitch is that employers can provide access to personalised protocols and supplements as part of a modern benefits package.

The company also states that early validation is already in motion, including signing its first LOIs with Bay Area tech startups. Co-founder Paweł Chrzan explains the U.S. choice as a speed advantage—arguing it’s a market where innovation reaches companies and users faster—and adds that the employee benefits model is a natural fit because the workplace is where lifestyle changes can be introduced with a better chance of consistency.

This “benefits-first” wedge is especially relevant for the ai world summit 2025 / 2026 audience, because it mirrors what many AI startups are doing in enterprise: they enter through a budget line that already exists, attach to a measurable business problem, and then expand once engagement proves real. For the ai world organisation, it’s also a reminder that distribution design is often the hidden differentiator, which is why go-to-market execution remains a major track across ai world organisation events and ai conferences by ai world.

Mos Health also notes support from external advisors, including commercial advisor Misa Beach (formerly of OpenAI) and clinical advisor Dr Oliver Zolman, described as a longevity specialist and a co-creator of the Blueprint Protocol with Bryan Johnson. Advisors like these can help a young team balance product speed with credibility, especially in categories where trust, safety, and user expectations are high.